Prof. Christel Middeldorp
Director (29 July 2019 - November 2022)
Professor Middeldorp’s research focuses on the role of genetic and other familial factors in the development and persistence of common psychiatric symptoms in childhood, including ADHD. She also investigates the role of parental mental health problems, on the outcome of psychiatric symptoms in a clinical cohort and will perform a trial to study whether addressing parental mental health also improves the outcome for the children. Christel is committed to facilitating patient advocacy, increasing stakeholder representation and establishing an essential large network to investigate ADHD on the large scale that is necessary to identify biomarkers.
Assoc Prof. Tim Silk
Director (29 July 2019 - 30 July 2022)
Assoc Prof. Tim Silk is a cognitive neuroscientist specializing in paediatric neurodevelopmental imaging in order to understand the brain-behaviour interface; when and where that goes awry. Tim heads the Brain and Cognitive Development Lab, and currently leads The Neuroimaging of the Children’s Attention Project (NICAP) collecting longitudinal multimodal neuroimaging data in order to understand how brain structure and function change across late childhood to early adolescence for children with and without ADHD, and how those changes reflect ADHD symptom severity and functional outcomes.
Dr Paul Hutchins
Board Member (14 November 2018 - March 2020)
Dr Paul Hutchins is a Senior Paediatric Consultant to The Children’s Hospital Education Research Institute, which he helped establish, an Honorary Medical Officer at the Children’s Hospital, Westmead and an Honorary Associate at Sydney Medical School, University of Sydney. Paul has over 35 years of tertiary developmental practice and collaboration with educators, parents, support groups and health professionals. He has contributed to Australian and international guidelines for ADHD management and chaired the Stimulant Subcommittee NSW for nearly 20 years.
Dr Michele Toner
Director (29 July 2017 - 26 July 2019)
Michele works in private practice as a specialist ADHD coach. Trained as a teacher, she developed a special interest in students who learn differently, which ultimately led her to ADHD coaching. She has spent 20 years’ in ADHD Advocacy on a state and national level and has strong connections to community, academic and professional networks. Michele worked with others to form the national consumer advocacy group ADHD Australia and was a member of their inaugural board. Michele is committed to evidence-based approaches, coaching adults, adolescents and children. Michele also trains coaches as a faculty member of the ADD Coach Academy in New York and is a registered mentor coach.
Prof. Vicki Anderson
Director (29 July 2017 - 27 July 2018)
Vicki is a paediatric neuropsychologist with over 30 years of experience. She has published over 250 papers in peer-reviewed journals, as well as four books and has obtained competitive research grants totalling over $20 million. Her research focuses on improving our understanding of childhood-acquired brain injury, chronic illness and neurodevelopmental disorders. She is an NHMRC Senior Practitioner Fellow, and a Fellow of the Academy of Social Sciences Australia, the Australian Psychological Society and the Australasian Society for the Study of Brain Impairment.
Assoc Prof. Daryl Efron
Director (29 July 2017 - 27 July 2018)
Daryl is a paediatrician who has worked at the Royal Children’s Hospital for over 25 years and currently holds appointments as a general paediatrician in the Department of General Medicine at the Royal Children’s Hospital, senior lecturer in the University of Melbourne Department of Paediatrics, and senior research fellow in the Murdoch Children’s Research Institute. Daryl is active in research, particularly into ADHD, and is one of the lead investigators of the longitudinal Children’s Attention Project.
Dr Alicia Montgomery
Appointed Director (March 2020 - 31 January 2023)
Dr Alicia Montgomery is a specialist in developmental and behavioural Paediatrics with an interest in transdiagnostic neurodevelopmental clinical practice and research. Dr Montgomery is currently leading an interdisciplinary project for the Sydney Local Health District on new models of care for ADHD and is also currently running pharmacological clinical trials in Autism Spectrum Disorder and Tourette Syndrome for the School of Psychiatry at the University of New South Wales. Alicia is a member of the Neurodevelopmental and Behavioural Paediatric Society of Australasia and represents the NBPSA on the Royal Australian College of Physicians’ Committee for Community Child Health.